A phase IB clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00VP, administered at 2 different dosing schedules, in HIV-1-uninfected adult participants

Trial Profile

A phase IB clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00VP, administered at 2 different dosing schedules, in HIV-1-uninfected adult participants

Completed
Phase of Trial: Phase I/II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs VRC-HIVDNA009-00-VP (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 05 Oct 2007 Status changed from in progress to completed.
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top